Want to join the conversation?
$BMY 2Q15 Call: Delivered 7% overall sales growth YoverY. For Opdivo, had three early study stops, significant data presented at ASCO, three filings, three approvals, and commercial launches in both US & Europe. In Europe, Opdivo was approved for squamous lung cancer in this week. Expects to complete filing of 57 data in US & Europe in this week.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!